Work

Alrizomadlin (APG-115) alone or in combination with lisaftoclax (APG-2575) for the treatment of pediatric patients with relapsed/metastatic rhabdomyosarcoma (RMS) or other soft-tissue sarcomas (STSs).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.10012

Authors: Yizhuo Zhang, YI Zhang, Suying Lu, Weiling Zhang, Juan Wang, Feifei Sun, Aiguo Liu, Junting Huang, Yizhuo Wang, Jing Li, Yan Yu, Lichuang Men, Haixiao Chen, Dajun Yang, Yifan Zhai

Institutions: Beijing Tongren Hospital, Capital Medical University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Tongji Hospital, Huazhong University of Science and Technology, Ascentage Pharma Group Inc. (United States)

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162546757

Cites:

Cited by:

Related to: